• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED

20.0% ! 0.2¢
Market Cap $0  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM
Chimeric: Media Thread
16 17 18
14:00 1.0K 456K
14:00 Last post  Shellbell Comments Created with Sketch.  1.0K  Views Created with Sketch.  456K 
CHM 16/01/26 57 16K
16/01/26 Last post  dalts66 Comments Created with Sketch.  57  Views Created with Sketch.  16K 
CHM 09/01/26 0 464
09/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  464 
CHM 08/01/26 2 894
08/01/26 Last post  Steini Comments Created with Sketch.  2  Views Created with Sketch.  894 
CHM 07/01/26 0 300
07/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  300 
CHM 05/01/26 0 547
05/01/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  547 
CHM 02/01/26 81 15K
02/01/26 Last post  Steini Comments Created with Sketch.  81  Views Created with Sketch.  15K 
CHM 01/01/26 3 1K
01/01/26 Last post  Beaza79 Comments Created with Sketch.  3  Views Created with Sketch.  1K 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
09 Jan 16:20
 
Notice under section 708A
07 Jan 16:12
 
Application for quotation of securities - CHM
07 Jan 16:09
 
Ceasing to be a substantial holder
05 Jan 16:45
 
Notice under section 708A
31 Dec 12:23
 
Application for quotation of securities - CHM
31 Dec 12:13
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.2¢
Change
-0.001(20.0%)
Mkt cap ! N/A
Open High Low Volume
0.2¢ 0.2¢ 0.2¢ 111.8K

Buyers (Bids)

Vol. Price($)
166114990 0.2¢
 

Sellers (Offers)

Price($) Vol.
0.3¢ 89415220
Last trade - 16.10pm 23/01/2026 (20 minute delay) ?
CHM (ASX) Chart
Capital Compass
AGE
AGE
ALLIGATOR ENERGY LIMITED
Dr Andrea Marsland-Smith, CEO
Dr Andrea Marsland-Smith
CEO
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.